期刊文献+

克拉霉素为主短程三联疗法根除幽门螺杆菌的临床对照研究 被引量:6

Randomly Controlled Trial of Triple Regimens Containing Clarithromycin for Eradication of H. Pylori
下载PDF
导出
摘要 目的:评价以克拉霉素为基础的短程(1周)三联疗法的幽门螺杆菌(HP)根除率。方法:采用随机对照临床试验。132例十二指肠球部溃疡(OU)和慢性胃炎(CG)HP阳性患者随机分为4个治疗组:OAC组、OFC组、OFA组、OMC组。OFA组,bid,疗程均为1周。治疗结束后4~8周作^(13)C-尿素呼气试验判断HP根除率的效果。结果:实际完成治疗127例,不同方案的HP根除率分别为:OAC组90.3%,OFC组90.9%,OMC组70.9%,及OFA组65.6%。结论:OAC组和OFC疗法对HP具有相当高的根除率,含克拉霉素的三联疗法OAC和OFC方案是适合我国国情的根除HP行之有效的方案。 Objective: To assess eradicating rates of H. pylori(HP) with short course (one week) triple regimens containing clarithromycin. Method: A clinical controlled trial was conducted in 134 cases of patients, with duodenal ulcer (DU) and chronic gastritis associated with positive HP, which were randomly divided into four treated groups (OAC, OFC, OMC, and OFA). All patients took drug two times daily, the treatment course of every patient was one week. C expiration test was conducted 4-8 weeks after the and of treatment course, determining the effect of HP-eradicated. Result; 127 cases have completed whole course in pratice. The eradicating rates of different regimens were 90.3 % (OAC), 90. 9 % (OFC), 70.9 % (OMC), and 65.6 %(OFA), respectively. Conclusion; There were obvious eradicating rate with the treament regimens-OAC and OFC. The OAC0 and OFC regimens of triple therapy containing clarithromycin were effective regimen of eradicating H. Pylori in the specific state of our country.
出处 《中国药师》 CAS 2000年第6期357-358,共2页 China Pharmacist
关键词 克拉霉素 幽门螺杆菌 短程三联疗法 药物治疗 Clarithromycin H. Pylori Controlled trial
  • 相关文献

参考文献2

二级参考文献1

  • 1F. Szczebara,L. Dhaenens,P. Vincent,M. O. Husson. Evaluation of rapid molecular methods for detection of clarithromycin resistance inHelicobacter pylori[J] 1997,European Journal of Clinical Microbiology & Infectious Diseases(2):162~164

共引文献9

同被引文献20

  • 1许筱,周云芳,叶菊芬.氧氟沙星与氟罗沙星治疗下呼吸道感染的疗效与药物经济学分析[J].医药导报,2004,23(7):507-509. 被引量:31
  • 2宋秉鹏,丁玉峰.药物经济学概述[J].药物流行病学杂志,1996,5(3):179-183. 被引量:305
  • 3[1]Gisbert JP, Khorrami S, Calvet X, et al. Rabeprazole-based therapies in Helicobacter pylori eradication[J].Aliment Pharmacol Ther. 2003,17(6):751.
  • 4[2]Zanten SJ, Bradette M, Farley A, et al. The DU-MACH study: eradication of Helicobacter pylori and ulcer healing in patients with acute duodenal ulcer using omeprazole based triple therapy[J]. Aliment Pharmacol Ther,1999,13(3):289.
  • 5[3]Ulmer HJ, Beckerling A, Gatz G. Recent use of proton pump inhibitor-based triple therapies for the eradication of H pylori: a broad data review[J]. Helicobacter,2003,8(2):95.
  • 6李瑜元.幽门螺杆菌感染的分析和治疗进展[M].上海:上海教育出版社,1999:170-198.
  • 7Malfertheiner P, Bayerdorffer E,Diete U, Gil J,Lind T, Misiuna P,O'morain C,Sipponen P, Spiller RC,Stesiewicz J,Treichel H, Ujszaszy L,Unge P, Zanten ST, Zeijlon L. The GU-MACH study:the efface of 1-week omeprazole triple therapy on Helicobacter pylori infection in patients with gastric ulcer[J]. Aliment Pharmacol Ther, 1999; 13 (6): 703-712
  • 8Brandimarte G, Tursi A, di Cesare L, Gosbarrini G. Antimicrobial treatment for peptic stenosis: a prespective study[J]. Fur J Gastroenterol Hepatol, 1999, 11(7): 731-734
  • 9成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 10何志高,陈洁,张丹.药物经济学研究中成本的确定[J].中国药房,1998,9(3):100-101. 被引量:148

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部